
Please contact the doctor's office to verify that your insurance is accepted.
Massimo Cristofanilli, MD, is an accomplished board-certified medical oncologist with more than two decades of experience as physician, investigator, researcher and leader. He has demonstrated original and innovative vision in the field of molecular diagnostics, liquid biopsy, translational research and drug development. Additionally, Dr. Cristofanilli has an extensive background in clinical trial design and is a key thought leader in the field of metastatic and locally advanced breast cancer. At Weill Cornell Medicine and NewYork-Presbyterian, Dr. Cristofanilli serves as the Associate Director of Precision Oncology at the Meyer Cancer Center (MCC), and the co-leader of the MCC Breast Can...
Camizestrant at detection of ESR1 mutation improves survival for advanced breast cancer
Liquid biopsies' alert advanced breast cancer patients when new drugs are needed
Implementing liquid biopsy in HR+/HER2- metastatic breast cancer: challenges and opportunities.
Associations of neighborhood deprivation with breast cancer tumor genomics, targeted treatment use, and survival.
Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated Cells.